Literature DB >> 29489034

Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study.

Ioannis Andrikou1, Costas Tsioufis1, Kyriakos Dimitriadis1, Dimitrios Konstantinidis1, Alexandros Kasiakogias1, Mairi Kouremeti1, Eirini Andrikou1, Ioanna Karapati1, Theodoros Kalos1, Christos Fragoulis1, Ioannis Liatakis1, Evaggelia Koutra1, Konstantinos Kyriazopoulos1, Costas Thomopoulos1, Dimitrios Tousoulis1.   

Abstract

The role of serum uric acid (SUA) in cardiovascular risk prediction remains to be further determined. We assessed the predictive value of SUA for the incidence of coronary artery disease (CAD) in 2287 essential hypertensive patients who were followed up for a mean period of 8 years. The distribution of SUA levels at baseline was split by the median (5.2 mg/dL) and subjects were classified into those with high and low values. Hypertensives who developed CAD (n = 57) compared to those without CAD at follow-up (n = 2230) had at baseline higher SUA. In multivariate Cox regression model, among established confounders, high SUA (hazard ratio = 1.216, P = .016) turned out to be independent predictor of CAD. In essential hypertensive patients SUA independently predicts CAD.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  coronary artery disease; essential hypertension; uric acid

Mesh:

Substances:

Year:  2018        PMID: 29489034     DOI: 10.1111/1440-1681.12928

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?

Authors:  Vivianne Presta; Barbara Citoni; Giuliano Tocci
Journal:  Intern Emerg Med       Date:  2019-05-13       Impact factor: 3.397

2.  Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT.

Authors:  Siling Xu; Lu Liu; Guoqing Yin; Abdul-Quddus Mohammed; Xian Lv; Cailing Feng; Tingting Shi; Fuad A Abdu; Wenliang Che
Journal:  Clin Interv Aging       Date:  2021-11-16       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.